✦ LIBER ✦

9154 Clinical outcomes in patients with EGFR mutations: pooled analysis of NSCLC patients treated with either an EGFR TKI or chemotherapy

✍ Scribed by Paz-Ares, L.; Soulières, D.; Klughammer, B.; Melezínek, I.; Moecks, J.; Keil, L.; Mok, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Is there any predictor for clinical outc

✍ Lee, Ji Yun; Lim, Sung Hee; Kim, Moonjin; Kim, Sungmin; Jung, Hyun Ae; Chang, Wo 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 258 KB

6522 POSTER EGFR mutations and response

✍ Crinó, L.; Ludovini, V.; Pistola, L.; Floriani, I.; Betti, M.; Chiari, R.; Giuff 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

EGFR CA repeat polymorphism predict clin

✍ Winther Larsen, Anne; Nissen, Peter Henrik; Meldgaard, Peter; Weber, Britta; Sor 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 695 KB

Overcoming resistance to first generatio

✍ Pircher, A.; Manzl, C.; Fiegl, M.; Popper, H.; Pirker, R.; Hilbe, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 936 KB

27 Risk of CNS progression in EGFR mutat

✍ Walter, H.S.; Plant, R.; Chauhan, M.; Fennell, D.A.; Ahmed, S.I. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 45 KB

414 Correlation of mutations in EGFR wit

✍ D. Eberhard; L. Amler; A. Goddard; W. Ince; T. Januario; K. Hillan; M. Ostland; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 143 KB